How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market.

Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (Pharma and Medtech brand strategist and founder of NMBLR) about how market access, HEOR and commercialisation leads in Pharma and Medtech can best support overarching product and brand strategy, with a focus on launch challenges in the US market.

We take a step back from the intricacies of market access and HEOR, to explore the role our specialism plays in broader commercial and product strategy. We ask: where does market access and HEOR sit in this broader picture, and how can market access teams best support their product and company brand?

Using the US market as our case study, we explore:

- How to set up your product for success
- Commercialisation routes in the US for Pharma and Medtech
- The relationship between brand strategy and market access
- What Pharma can learn from Medtech’s approach to commercialisation
- What Medtech innovators can learn from Pharma companies’ approach to launch

This episode was first broadcast as a live webinar in January 2024.

Learn more at: https://mtechaccess.co.uk/commercialisation-strategy-us-market/

Explore our work in the US market: https://mtechaccess.co.uk/launching-healthcare-products-in-the-us/

Discover how Mtech Access can support you global market access and pricing strategy: https://mtechaccess.co.uk/global-market-access-and-pricing/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.